Search

Search Constraints

You searched for: Author/Creator Stättermayer, Albert F.

Search Results

1. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension. Issue 9 (September 2022)

2. Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon‐Free Therapy. Issue 3 (14th October 2019)

3. Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment. (1st December 2017)

4. Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension. (3rd December 2019)

5. Long‐term follow‐up of ribavirin‐free DAA‐based treatment in HCV recurrence after orthotopic liver transplantation. (31st January 2018)

6. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease. Issue 4 (16th March 2021)

7. Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease. (22nd January 2020)

8. Revisiting liver disease progression in HIV/HCV‐coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3. (26th June 2014)

9. Role of FDFT1 polymorphism for fibrosis progression in patients with chronic hepatitis C. (21st July 2013)